Cargando…
Short-term budget affordability of hepatitis C treatments for state Medicaid programs
BACKGROUND: With some Medicaid state programs still restricting patient access to hepatitis C (HCV) treatment, it is important to demonstrate how states could expand treatment access to a broader Medicaid population and balance short-term budget concerns. METHODS: We used the HCV Transmission and Pr...
Autores principales: | Chou, Jacquelyn W., Silverstein, Alison R., Goldman, Dana P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394005/ https://www.ncbi.nlm.nih.gov/pubmed/30819153 http://dx.doi.org/10.1186/s12913-019-3956-x |
Ejemplares similares
-
Overview of Comprehensive Hepatitis C Virus Medication Management in a State Medicaid Program
por: Lavitas, Pavel, et al.
Publicado: (2016) -
The Affordable Care Act Medicaid Expansions and Personal
Finance
por: Caswell, Kyle J., et al.
Publicado: (2017) -
Transparency and Accountability of Medicaid Section 1115 Waiver Demonstration Programs Under the Affordable Care Act
por: Lopez, Leo, et al.
Publicado: (2020) -
Budget Impact of Medicaid Section 1115 Demonstrations for Early HIV Treatment
por: Schackman, Bruce R., et al.
Publicado: (2005) -
Affordability of oncology drugs: accuracy of budget impact estimations
por: Geenen, Joost W., et al.
Publicado: (2019)